Cryo-Cell Intl Inc (CCEL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 11/30
| 11-2020 | 08-2020 | 05-2020 | 02-2020 | 11-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 10,361 | 8,108 | 8,420 | 8,416 | 6,541 |
| Marketable Securities | 89 | 63 | 905 | 959 | 904 |
| Receivables | 6,323 | 6,504 | 5,975 | 5,767 | 6,097 |
| Inventories | 927 | 1,203 | 1,054 | 1,103 | 1,085 |
| Other current assets | 245 | 287 | 242 | 199 | 260 |
| TOTAL | $18,556 | $16,764 | $17,280 | $16,895 | $15,388 |
| Non-Current Assets | |||||
| PPE Net | 1,641 | 1,664 | 1,739 | 1,775 | 1,847 |
| Investments And Advances | 308 | 308 | 308 | 308 | 308 |
| Intangibles | 3,473 | 3,490 | 3,157 | 3,174 | 3,191 |
| Other Non-Current Assets | 22,222 | 22,215 | 22,357 | 22,579 | 22,153 |
| TOTAL | $27,644 | $27,677 | $27,561 | $27,836 | $27,499 |
| Total Assets | $46,200 | $44,440 | $44,841 | $44,731 | $42,886 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 957 | 900 | 952 | 1,381 | 1,369 |
| Accrued Expenses | 2,898 | 1,049 | 1,939 | 2,714 | 2,085 |
| TOTAL | $16,415 | $14,428 | $15,099 | $16,070 | $15,429 |
| Non-Current Liabilities | |||||
| Long Term Debt | 2,841 | 3,598 | 4,353 | 5,106 | 5,856 |
| Deferred Revenues | 9,184 | 9,107 | 8,840 | 8,610 | 8,875 |
| Other Non-Current Liabilities | 2,409 | 4,249 | 5,059 | 5,100 | 4,920 |
| TOTAL | $32,451 | $34,049 | $34,725 | $34,661 | $34,410 |
| Total Liabilities | $48,865 | $48,477 | $49,823 | $50,731 | $49,839 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 7,571 | 7,546 | 7,546 | 7,546 | 7,546 |
| Common Shares | 136 | 136 | 136 | 136 | 136 |
| Retained earnings | -18,820 | -20,020 | -20,804 | -21,757 | -22,444 |
| Other shareholders' equity | 437 | 437 | 437 | 437 | 437 |
| TOTAL | $-2,665 | $-4,036 | $-4,983 | $-6,001 | $-6,953 |
| Total Liabilities And Equity | $46,200 | $44,440 | $44,841 | $44,731 | $42,886 |